Active Filters

  • (-) PSI Authors = Schibli, Roger
  • (-) Journals = Journal of Nuclear Medicine
Search Results 1 - 20 of 24
Select Page
<sup>161</sup>Tb-DOTATOC production using a fully automated disposable cassette system: a first step toward the introduction of <sup>161</sup>Tb into the clinic
Favaretto, C., Grundler, P. V., Talip, Z., Landolt, S., Sepini, L., Köster, U., … van der Meulen, N. P. (2023). 161Tb-DOTATOC production using a fully automated disposable cassette system: a first step toward the introduction of 161Tb into the clinic. Journal of Nuclear Medicine, 64(7), 1138-1144. https://doi.org/10.2967/jnumed.122.265268
Signaling network response to <em>α</em>-particle–targeted therapy with the <sup>225</sup>Ac-labeled minigastrin analog <sup>225</sup>Ac-PP-F11N reveals the radiosensitizing potential of histone deacetylase inhibitors
Qin, Y., Imobersteg, S., Frank, S., Blanc, A., Chiorazzo, T., Berger, P., … Grzmil, M. (2023). Signaling network response to α-particle–targeted therapy with the 225Ac-labeled minigastrin analog 225Ac-PP-F11N reveals the radiosensitizing potential of histone deacetylase inhibitors. Journal of Nuclear Medicine, 64(6), 873-879. https://doi.org/10.2967/jnumed.122.264597
Albumin-binding and conventional PSMA ligands in combination with <sup>161</sup>Tb: biodistribution, dosimetry, and preclinical therapy
Tschan, V. J., Busslinger, S. D., Bernhardt, P., Grundler, P. V., Zeevaart, J. R., Köster, U., … Müller, C. (2023). Albumin-binding and conventional PSMA ligands in combination with 161Tb: biodistribution, dosimetry, and preclinical therapy. Journal of Nuclear Medicine, 64(10), 1625-1631. https://doi.org/10.2967/jnumed.123.265524
First-in-human application of terbium-161: a feasibility study using <sup>161</sup>Tb-DOTATOC
Baum, R. P., Singh, A., Kulkarni, H. R., Bernhardt, P., Rydén, T., Schuchardt, C., … Müller, C. (2021). First-in-human application of terbium-161: a feasibility study using 161Tb-DOTATOC. Journal of Nuclear Medicine, 62(10), 1391-1397. https://doi.org/10.2967/jnumed.120.258376
Identification of a PET radiotracer for imaging of the folate receptor-α: a potential tool to select patients for targeted tumor therapy
Guzik, P., Fang, H. Y., Deberle, L. M., Benešová, M., Cohrs, S., Boss, S. D., … Müller, C. (2021). Identification of a PET radiotracer for imaging of the folate receptor-α: a potential tool to select patients for targeted tumor therapy. Journal of Nuclear Medicine, 62(10), 1475-1481. https://doi.org/10.2967/jnumed.120.255760
Cholecystokinin-2 receptor agonist <sup>177</sup>Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - results of the lumed phase 0a study
Rottenburger, C., Nicolas, G. P., McDougall, L., Kaul, F., Cachovan, M., Vija, A. H., … Wild, D. (2020). Cholecystokinin-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - results of the lumed phase 0a study. Journal of Nuclear Medicine, 61(4), 520-526. https://doi.org/10.2967/jnumed.119.233031
Diastereomerically pure 6&lt;em&gt;R&lt;/em&gt;- and 6&lt;em&gt;S&lt;/em&gt;-3&#039;-aza-2&#039;-&lt;sup&gt;18&lt;/sup&gt;F-fluoro-5-methyltetrahydrofolates show unprecedentedly high uptake in folate receptor-positive KB tumors
Boss, S. D., Müller, C., Siwowska, K., Schmid, R. M., Groehn, V., Schibli, R., & Ametamey, S. M. (2019). Diastereomerically pure 6R- and 6S-3'-aza-2'-18F-fluoro-5-methyltetrahydrofolates show unprecedentedly high uptake in folate receptor-positive KB tumors. Journal of Nuclear Medicine, 60(1), 135-141. https://doi.org/10.2967/jnumed.118.213314
First clinico-pathological evidence of a non PSMA-related uptake mechanism for &lt;sup&gt;68&lt;/sup&gt;Ga-PSMA-11 in salivary glands
Rupp, N. J., Umbricht, C. A., Pizzuto, D. A., Lenggenhager, D., Töpfer, A., Müller, J., … Burger, I. A. (2019). First clinico-pathological evidence of a non PSMA-related uptake mechanism for 68Ga-PSMA-11 in salivary glands. Journal of Nuclear Medicine, 60(9), 1270-1276. https://doi.org/10.2967/jnumed.118.222307
Therapeutic radiometals beyond <sup>177</sup>Lu and <sup>90</sup>Y: production and application of promising α-particle, β<sup>–</sup>-particle, and Auger electron emitters
Müller, C., van der Meulen, N. P., Benešová, M., & Schibli, R. (2017). Therapeutic radiometals beyond 177Lu and 90Y: production and application of promising α-particle, β-particle, and Auger electron emitters. Journal of Nuclear Medicine, 58(Suppl. 2), 91S-96S. https://doi.org/10.2967/jnumed.116.186825
Dosimetry and first clinical evaluation of the new <sup>18</sup>F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer
Sah, B. R., Burger, I. A., Schibli, R., Friebe, M., Dinkelborg, L., Graham, K., … Schaefer, N. G. (2015). Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer. Journal of Nuclear Medicine, 56(3), 372-378. https://doi.org/10.2967/jnumed.114.147116
Promising prospects for <sup>44</sup>Sc-/<sup>47</sup>Sc-based theragnostics: application of <sup>47</sup>Sc for radionuclide tumor therapy in mice
Müller, C., Bunka, M., Haller, S., Köster, U., Groehn, V., Bernhardt, P., … Schibli, R. (2014). Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice. Journal of Nuclear Medicine, 55(10), 1658-1664. https://doi.org/10.2967/jnumed.114.141614
Tumor imaging in patients with advanced tumors using a new <sup>99m</sup>Tc-radiolabeled vitamin B12 derivative
Sah, B. R., Schibli, R., Waibel, R., Von Boehmer, L., Bläuenstein, P., Nexo, E., … Burger, I. A. (2014). Tumor imaging in patients with advanced tumors using a new 99mTc-radiolabeled vitamin B12 derivative. Journal of Nuclear Medicine, 55(1), 43-49. https://doi.org/10.2967/jnumed.113.122499
Quantification of brain glucose metabolism by <sup>18</sup>F-FDG PET with real-time arterial and image-derived input function in mice
Alf, M. F., Wyss, M. T., Buck, A., Weber, B., Schibli, R., & Krämer, S. D. (2013). Quantification of brain glucose metabolism by 18F-FDG PET with real-time arterial and image-derived input function in mice. Journal of Nuclear Medicine, 54(1), 132-138. https://doi.org/10.2967/jnumed.112.107474
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted &lt;sup&gt;177&lt;/sup&gt;Lu-radionuclide tumor therapy in mice
Müller, C., Struthers, H., Winiger, C., Zhernosekov, K., & Schibli, R. (2013). DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice. Journal of Nuclear Medicine, 54(1), 124-131. https://doi.org/10.2967/jnumed.112.107235
Promises of cyclotron-produced <sup>44</sup>Sc as a diagnostic match for trivalent β<sup>-</sup>-emitters: in vitro and in vivo study of a <sup>44</sup>Sc-DOTA-folate conjugate
Müller, C., Bunka, M., Reber, J., Fischer, C., Zhernosekov, K., Türler, A., & Schibli, R. (2013). Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate. Journal of Nuclear Medicine, 54(12), 2168-2174. https://doi.org/10.2967/jnumed.113.123810
5-(2-&lt;sup&gt;18&lt;/sup&gt;F-fluoroethoxy)-&lt;sub&gt;L&lt;/sub&gt;-tryptophan as a substrate of system L transport for tumor imaging by PET
Krämer, S. D., Mu, L., Müller, A., Keller, C., Kuznetsova, O. F., Schweinsberg, C., … Ametamey, S. M. (2012). 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET. Journal of Nuclear Medicine, 53(3), 434-442. https://doi.org/10.2967/jnumed.111.096289
A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β<sup>−</sup>-radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative
Müller, C., Zhernosekov, K., Köster, U., Johnston, K., Dorrer, H., Hohn, A., … Schibli, R. (2012). A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β-radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative. Journal of Nuclear Medicine, 53(12), 1951-1959. https://doi.org/10.2967/jnumed.112.107540
Recording intracellular molecular events from the outside: glycosylphosphatidylinositol-anchored avidin as a reporter protein for in vivo imaging
Lehmann, S., Garcia Garayoa, E., Blanc, A., Keist, R., Schibli, R., & Rudin, M. (2011). Recording intracellular molecular events from the outside: glycosylphosphatidylinositol-anchored avidin as a reporter protein for in vivo imaging. Journal of Nuclear Medicine, 52(3), 445-452. https://doi.org/10.2967/jnumed.110.082412
Folic acid conjugates for nuclear imaging of folate receptor-positive cancer
Müller, C., & Schibli, R. (2011). Folic acid conjugates for nuclear imaging of folate receptor-positive cancer. Journal of Nuclear Medicine, 52(1), 1-4. https://doi.org/10.2967/jnumed.110.076018
A new <sup>18</sup>F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors
Ross, T. L., Honer, M., Müller, C., Groehn, V., Schibli, R., & Ametamey, S. M. (2010). A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors. Journal of Nuclear Medicine, 51(11), 1756-1762. https://doi.org/10.2967/jnumed.110.079756